Baudax Bio to Present at NobleCon18 Investor Conference
Baudax Bio (NASDAQ:BXRX) announced that CEO Gerri Henwood will present at the Noble Capital Markets’ 18th Annual Investor Conference on April 20, 2022, at 3:30 p.m. ET in Hollywood, Florida. A webcast of this presentation will be available the next day on the company's website along with an archived version for 90 days.
Additionally, Henwood will participate in breakout sessions on April 20 at 12:15 p.m. ET and April 21 at 10:45 a.m. ET, providing further engagement opportunities.
- None.
- None.
MALVERN, Pa., April 13, 2022 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present at the Noble Capital Markets’ 18th Annual Investor Conference (NobleCon18), taking place in Hollywood, Florida on Wednesday, April 20, 2022, at 3:30 p.m. Eastern Time.
A webcast of the presentation will be available the following day on the “Events” page within the investors section of the Baudax Bio website at https://www.baudaxbio.com/news-and-investors. The webcast will be archived on the company’s website, the NobleCon website, and on Channelchek.com for 90 days following the event.
There is also the opportunity to meet with Ms. Henwood at two breakout sessions scheduled for Wednesday, April 20, 2022, at 12:15 p.m. ET and Thursday, April 21, 2022, at 10:45 a.m. ET.
About Baudax Bio
Baudax Bio is a pharmaceutical company focused on commercializing and developing innovative products for acute care settings. ANJESO is the first and only 24-hour, intravenous (IV) COX-2 preferential non-steroidal anti-inflammatory (NSAID) for the management of moderate to severe pain. In addition to ANJESO, Baudax Bio has a pipeline of other innovative pharmaceutical assets including two novel neuromuscular blocking agents (NMBs) and a proprietary chemical reversal agent specific to these NMBs. For more information, please visit www.baudaxbio.com.
CONTACT:
Investor Relations Contact:
Argot Partners
Sam Martin / Kaela Ilami
(212) 600-1902
baudaxbio@argotpartners.com
Media Contact:
Argot Partners
David Rosen
(212) 600-1902
david.rosen@argotpartners.com
FAQ
When is Gerri Henwood presenting at NobleCon18 for Baudax Bio (BXRX)?
Where can I watch the Baudax Bio (BXRX) presentation webcast?
What opportunities are there to meet Gerri Henwood at NobleCon18?
What is the focus of Baudax Bio (BXRX)?
